[Federal Register Volume 91, Number 38 (Thursday, February 26, 2026)]
[Notices]
[Pages 9617-9618]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2026-03877]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2026-0199]
Meeting of the Advisory Committee on Immunization Practices
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting of the Advisory Committee on Immunization Practices
(ACIP). Time will be available for public comment.
DATES: The meeting will be held on March 18, 2026, from 8 a.m. to 5
p.m., EST, and March 19, 2025, from 8 a.m. to 5 p.m., EST, (times
subject to change; see the ACIP website for updates: https://www.cdc.gov/vaccines/acip/index.html). The meeting is expected to be
held at the Centers for Disease Control and Prevention, with virtual
option. Written comments must be received between March 2--12, 2026.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2026-
0199, by either of the methods listed below. CDC does not accept
comments by email.
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: ACIP Secretariat, ACIP Meeting, Centers for Disease
Control and Prevention, 1600 Clifton Road NE, Mailstop H21-12, Atlanta,
Georgia 30329-4027. Attn: Docket No. CDC-2026-0199.
Instructions: All submissions received must include the Agency name
and docket number. For access to the docket to read background
documents or comments received, go to https://www.regulations.gov.
The meeting will be webcast live via the World Wide Web. The
webcast link can be found on the ACIP website at https://www.cdc.gov/acip.
FOR FURTHER INFORMATION CONTACT: ACIP Secretariat, Advisory Committee
on Immunization Practices, Centers for Disease Control and Prevention,
1600 Clifton Road NE, Mailstop H21-12, Atlanta, Georgia 30329-4027.
Email: [email protected].
SUPPLEMENTARY INFORMATION: Purpose: The Advisory Committee on
Immunization Practices is charged with advising the Director, Centers
for Disease Control and Prevention (CDC), on the use of immunizing
agents. In addition, under 42 U.S.C. 1396s, the Committee is mandated
to establish and periodically review and, as appropriate, revise the
list of vaccines for administration to vaccine-eligible children
through the Vaccines for Children program, along with schedules
regarding dosing interval, dosage, and contraindications to
administration of vaccines. Further, under applicable provisions of the
Affordable Care Act and section 2713 of the Public Health Service Act,
immunization recommendations of ACIP that have been adopted by the
Director, CDC, and appear on CDC immunization schedules generally must
be covered by applicable health plans.
Matters to be Considered: The agenda will include updates on ACIP
Workgroups and discussions on COVID-19 vaccine injuries and Long-COVID
and ACIP recommendation
[[Page 9618]]
methodology. Recommendation votes may be scheduled for COVID-19 vaccine
injuries and Long-COVID and ACIP recommendation methodology. Agenda
items are subject to change as priorities dictate. For more information
on the meeting agenda, visit https://www.cdc.gov/acip/meetings/index.html.
Meeting Information: The meeting will be webcast live via the World
Wide Web. For more information on ACIP, please visit the ACIP website:
https://www.cdc.gov/acip.
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data. Please note that
comments received, including attachments and other supporting
materials, are part of the public record and are subject to public
disclosure. Comments will be posted on https://www.regulations.gov.
Therefore, do not include any information in your comment or supporting
materials that you consider confidential or inappropriate for public
disclosure. If you include your name, contact information, or other
information that identifies you in the body of your comments, that
information will be on public display. CDC will review all submissions
and may choose to redact, or withhold, submissions containing private
or proprietary information such as Social Security numbers, medical
information, inappropriate language, or duplicate/near-duplicate
examples of a mass-mail campaign. CDC will carefully consider all
comments submitted into the docket.
Written Public Comment: The docket will be opened to receive
written comments March 2-12, 2026. Written comments must be received by
March 12, 2026.
Oral Public Comment: This meeting will include time for members of
the public to make an oral comment. Oral public comment will occur
before any scheduled votes, including all votes relevant to the ACIP's
Affordable Care Act and Vaccines for Children Program roles. Priority
will be given to individuals who submit a request to make an oral
public comment before the meeting according to the procedures below.
Procedure for Oral Public Comment: All persons interested in making
an oral public comment at the March 18--19, 2026, ACIP meeting must
submit a request at https://www.cdc.gov/acip/meetings/index.html
between March 2--12, 2026, and no later than 11:59 p.m., EST, March 12,
2026, according to the instructions provided.
If the number of persons requesting to speak is greater than can be
reasonably accommodated during the scheduled time, CDC will conduct a
random draw to determine the speakers for the scheduled public comment
session. CDC staff will notify individuals regarding their request to
speak by email by March 16, 2026. To accommodate the significant
interest in participation in the oral public comment session of ACIP
meetings, each speaker will be limited to three minutes, and each
speaker may speak only once per meeting.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2026-03877 Filed 2-25-26; 8:45 am]
BILLING CODE 4163-18-P